C

Cyclacel Pharmaceuticals
D

CYCC

0.34610
USD
0.00
(0.70%)
مغلق
حجم التداول
257
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
4,812,913
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    AVXL
    -0.35000
    (-4.03%)
    8.34000 USD
    C
    CLRB
    -0.02210
    (-6.63%)
    0.31100 USD
    D
    DCTH
    -0.670
    (-4.32%)
    14.850 USD
    P
    PTN
    -0.02500
    (-2.43%)
    1.00500 USD
    S
    SLS
    -0.06000
    (-4.55%)
    1.26000 USD
    المزيد
الأخبار
المقالات

العنوان: Cyclacel Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib, Sapacitabine, and plogosertib.